The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women: A case control study

Gynecologic and Obstetric Investigation

Volumn 64, Issue 2, 2007, Pages 84-88

  Jo, Hoenil ^a   Kang, Sokbom ^b   Kim, Sung Il ^a   Kim, Jae Weon ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a   Park, Sang Yoon ^b   Kang, Soon Beom ^a   Lee, Hyo Pyo ^a  

^a Seoul National University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

DNA repair gene; Endometrial Cancer; Excision repair cross complementing group 1; Ovarian Cancer; Polymorphism

Indexed keywords

DNA REPAIR PROTEIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; KOREA; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; ENDONUCLEASES; FEMALE; GENOTYPE; HUMANS; KOREA; LOGISTIC MODELS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; ODDS RATIO; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34548089715     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100008     Document Type: Article

References (26)

1. Korean Society of Obstetrics and Gynecology: Annual Report of Gynecologic Cancer Registry Program in Korea, 2002.
2. Gupta RC, Lutz WK: Background DNA damage for endogenous and unavoidable exogenous carcinogens: a basis for spontaneous cancer incidence? Mutat Res 1999;424:1-8.
3. Jackson AL, Loeb LA: The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001;477:7-21.
4. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B: Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-110.
5. Marin MS, Lopez-Cima MF, Garcia-Castro L, Pascual T, Marron MG, Tardon A: Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1788-1793.
6. Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2003;11:1513-1530.
7. Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, Kim CH, Park JH, Kam S, Kim IS, Jung TH: Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002;11:23-27.
8. Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q: Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1998;7:465-468.
9. Friedberg EC: How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22-33.
10. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S: Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73:39-85.
11. Hoeijmakers JH: Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-374.
12. de Laat WL, Jaspers NG, Hoeijmakers JH: Molecular mechanism of nucleotide excision repair. Genes Dev 1999;13:768-785.
13. de Boer J, Hoeijmakers JH: Nucleotide excision repair and human syndromes. Carcinogenesis 2000;21:458-460.
14. Bessho T, Sancar A, Thompson LH, Thelen MP: Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J Biol Chem 1997;272:3833-3837.
15. Enzlin JH, Scharer OD: The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif. EMBO J 2002;21:2045-2053.
16. Sturgis EM, Dahlstrom KR, Spitz MR, Wei Q: DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2002;128:1084-1088.
17. Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, Lee M, Liu J, Wrensch M: Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 2000;9:843-847.
18. Takebayashi Y, Nakayama K, Kanzaki A, Miyashita H, Ogura O, Mori S, Mutoh M, Miyazaki K, Fukumoto M, Pommier Y: Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors. Cancer Lett 2001;174:115-125.
19. Han J, Hankinson SE, Hunter DJ, De Vivo I: Genetic variations in XRCC2 and XRCC3 are not associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:330-331.
20. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Chen C: Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecol Oncol 2006;103:891-896.
21. Shen MR, Jones IM, Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-608.
22. Knudson AG Jr: Genetic predisposition to cancer. Birth Defects Orig Artic Ser 1989;25:15-27.
23. Shields PG, Harris CC: Molecular epidemiology and the genetics of environmental cancer. JAMA 1991;266:681-687.
24. Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, Harris AL, Wojnarowska F, Welsh KI: A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000;60:5612-5616.
25. Yu JJ, Lee KB, Mu C, Li Q, Abernathy TV, Bostick-Bruton F, Reed E: Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene. Int J Oncol 2000;16:555-560.
26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed.